Pfizer Wants High Court To Review 1st Circ. RICO Rulings
Pfizer Inc. has asked the U.S. Supreme Court to review three First Circuit rulings that its allegedly fraudulent marketing of Neurontin caused Aetna Inc., Kaiser Foundation Health Plan Inc. and Harden...To view the full article, register now.
Already a subscriber? Click here to view full article